Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Charles River Laboratories International News

    227,74 $ -4,88% -11,69 $
    In : 212,44 € | 17:44:16 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 939391
    ISIN: US1598641074
    US-Symbol: CRL
    Typ: Aktie

    Charles River Laboratories International News

    09.04.24 - Businesswire
    Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
    Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia ...
    04.04.24 - Businesswire
    Charles River to Perform Plasmid Production for Ship of Theseus
    Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-​resistant homeobox (HOX) family biologics, today ...
    04.04.24 - Businesswire
    Charles River to Perform Plasmid Production for Ship of Theseus
    Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-​resistant homeobox (HOX) family biologics, today ...
    01.04.24 - Businesswire
    Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
    Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-​leading team of oncology experts will attend the American Association for Cancer ...
    21.03.24 - Businesswire
    Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
    Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical ...
    14.03.24 - Businesswire
    Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
    Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics , Inc., a biotechnology company developing epigenetic gene therapies, today announced an ...
    29.02.24 - PR Newswire
    Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
    Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-​in-Human Use PR Newswire
    21.02.24 - Businesswire
    Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
    Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing ...
    20.02.24 - LYNX Analysen
    Die Kunst erfolgreicher Investments
    Es gibt zahllose Strategien, die darauf abzielen, den Markt zu schlagen und eine überdurchschnittliche Rendite zu erzielen. Die meisten davon taugen überhaupt nichts. Jetzt ...
    29.01.24 - Businesswire
    Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
    Building upon its flagship Endosafe ® cartridge technology, Charles River Laboratories International, Inc. (NYSE: CRL) has advanced this innovation one step further and combined ...
    13.11.23 - PR Newswire
    Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
    Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology PR Newswire
    21.09.23 - ARIVA.DE Redaktion
    S&P 500: derzeit 0,99 Prozent weniger (4.356 Pkt.)
    Am Aktienmarkt ist die Stimmung für den S&P 500 zur Stunde etwas getrübt. Gegenwärtig liegt das Aktienbarometer mit 0,99 Prozent im Minus.
    21.09.23 - ARIVA.DE Redaktion
    Börsen USA: Leichte Verluste für den S&P 500 (4.362 Pkt.)
    Die Aktie von Charles River Laboratories ist aktuell der größte Verlierer im S&P 500-Index. Der Auswahlindex verliert 0,87 Prozent auf 4.362 Punkte.
    13.09.23 - ARIVA.DE Redaktion
    S&P 500 heute kaum bewegt – Waters mit größtem Kursgewinn (4.474 Pkt.)
    Am Aktienmarkt findet der S&P 500 gegenwärtig keine klare Richtung. Der Auswahlindex verbessert sich nur minimal um 0,24 Prozent.
    21.08.23 - PR Newswire
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of ...
    18.07.23 - ARIVA.DE Redaktion
    Aktien USA: Leichte Gewinne im S&P 500 (4.558 Pkt.)
    Für den S&P 500-Index verlief der bisherige Aktienhandel heute positiv. Das Kursbarometer gewinnt 54 Punkte hinzu.
    18.07.23 - ARIVA.DE Redaktion
    US-Aktien: S&P 500 mit leichten Zugewinnen (4.553 Pkt.)
    An der Börse ist die Stimmung für den S&P 500 derzeit freundlich. Das Kursbarometer steigt deutlich um 0,70 Prozent.
    18.07.23 - PR Newswire
    CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
    CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. ...
    17.07.23 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL PR Newswire
    16.07.23 - PR Newswire
    Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
    Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit PR Newswire

    Newssuche

    Videos

    newspaper
    09:30 Uhr +34,15%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »